These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
682 related items for PubMed ID: 24090419
1. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors. Sethi KK, Verma SM. J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419 [Abstract] [Full Text] [Related]
2. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation. Wang Y, Guo H, Tang G, He Q, Zhang Y, Hu Y, Wang Y, Lin Z. Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872 [Abstract] [Full Text] [Related]
3. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors. Sethi KK, Verma SM, Prasanthi N, Sahoo SK, Parhi RN, Suresh P. Bioorg Med Chem Lett; 2010 May 15; 20(10):3089-93. PubMed ID: 20443227 [Abstract] [Full Text] [Related]
4. Docking, CoMFA and CoMSIA studies of a series of sulfonamides derivatives as carbonic anhydrase I inhibitors. Ghasemi JB, Meftahi N. J Enzyme Inhib Med Chem; 2013 Apr 15; 28(2):320-7. PubMed ID: 22146078 [Abstract] [Full Text] [Related]
5. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II. Huang H, Pan X, Tan N, Zeng G, Ji C. Eur J Med Chem; 2007 Mar 15; 42(3):365-72. PubMed ID: 17118494 [Abstract] [Full Text] [Related]
6. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R, Agnello S, Ferro S, De Luca L, Vullo D, Brynda J, Mader P, Supuran CT, Chimirri A. J Med Chem; 2010 Mar 25; 53(6):2401-8. PubMed ID: 20170095 [Abstract] [Full Text] [Related]
7. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis. Salmas RE, Senturk M, Yurtsever M, Durdagi S. J Enzyme Inhib Med Chem; 2016 Mar 25; 31(3):425-33. PubMed ID: 25950196 [Abstract] [Full Text] [Related]
10. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols. Almajan GL, Innocenti A, Puccetti L, Manole G, Barbuceanu S, Saramet I, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 May 02; 15(9):2347-52. PubMed ID: 15837323 [Abstract] [Full Text] [Related]
11. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors. Rosatelli E, Carotti A, Ceruso M, Supuran CT, Gioiello A. Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3422-5. PubMed ID: 24948563 [Abstract] [Full Text] [Related]
12. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases. De Luca L, Mancuso F, Ferro S, Buemi MR, Angeli A, Del Prete S, Capasso C, Supuran CT, Gitto R. Eur J Med Chem; 2018 Jan 01; 143():276-282. PubMed ID: 29197732 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT. Eur J Med Chem; 2014 Jan 01; 71():135-47. PubMed ID: 24291567 [Abstract] [Full Text] [Related]
14. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT. Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091 [Abstract] [Full Text] [Related]
15. Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides. Jaiswal M, Khadikar PV, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3283-90. PubMed ID: 15149691 [Abstract] [Full Text] [Related]
17. Quantitative structure-activity relationship (QSAR) studies on a series of 1,3,4-thiadiazole-2-thione derivatives as tumor-associated carbonic anhydrase IX inhibitors. Abdel-Hamid MK, Abdel-Hafez AA, El-Koussi NA, Mahfouz NM. J Enzyme Inhib Med Chem; 2009 Jun 21; 24(3):722-9. PubMed ID: 18720193 [Abstract] [Full Text] [Related]
18. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors. Weber A, Böhm M, Supuran CT, Scozzafava A, Sotriffer CA, Klebe G. J Chem Inf Model; 2006 Jun 21; 46(6):2737-60. PubMed ID: 17125213 [Abstract] [Full Text] [Related]
19. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms. Carradori S, Secci D, De Monte C, Mollica A, Ceruso M, Akdemir A, Sobolev AP, Codispoti R, De Cosmi F, Guglielmi P, Supuran CT. Bioorg Med Chem; 2016 Mar 01; 24(5):1095-105. PubMed ID: 26810710 [Abstract] [Full Text] [Related]
20. Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors. Nocentini A, Moi D, Balboni G, Onnis V, Supuran CT. Bioorg Chem; 2018 Apr 01; 77():293-299. PubMed ID: 29421705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]